UK markets close in 3 hours 17 minutes

ERYTECH Pharma S.A. (ERYP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.92-0.02 (-0.34%)
At close: 4:00PM EDT
5.80 -0.12 (-2.03%)
Pre-market: 08:00AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.94
Open6.11
Bid6.00 x 1400
Ask6.00 x 800
Day's range5.80 - 6.11
52-week range4.10 - 13.00
Volume56,666
Avg. volume1,088,443
Market cap171.458M
Beta (5Y monthly)1.92
PE ratio (TTM)N/A
EPS (TTM)-3.71
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est17.83
  • Globe Newswire

    Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2021.

    Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2021. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of ne

  • Globe Newswire

    ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer

    ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer No dose-limiting toxicity (DLT) reported in first two dose cohorts, leading to declaration of the maximum tolerated dose (MTD) at 100 U/kgEncouraging clinical activity observed in first patients Lyon (France) and Cambridge, MA (U.S.), October 4, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative the

  • Globe Newswire

    ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech

    ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech Cambridge, MA (U.S.) and Lyon (France), September 28, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the company’s participation in one-on-one investor meetings at the HealthTech Innovation Days (HTID) by France Biotech being held in Paris and virtually on